Skip to content
The Policy VaultThe Policy Vault

Noxafil — CareFirst (Caremark)

treatment of moderate to severe oropharyngeal candidiasis

Preferred products

  • fluconazole
  • itraconazole oral solution

Initial criteria

  • The request is for Noxafil oral suspension (immediate-release)
  • The patient has experienced an inadequate treatment response, intolerance, or has a contraindication to fluconazole AND itraconazole oral solution

Approval duration

1 month